Kathy Nicholls

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi request reprint Diabetic nephropathy--how might we prevent, retard, or cope with it?
    Kathy Nicholls
    Royal Melbourne Hospital, Parkville, Victoria
    Aust Fam Physician 34:933-6. 2005
  2. ncbi request reprint Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre
    Thanh T Nguyen
    Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Clin Experiment Ophthalmol 33:164-8. 2005
  3. doi request reprint Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique
    Mathu Selvarajah
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Melbourne, Australia
    Nephrol Dial Transplant 26:3195-202. 2011
  4. pmc Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
    Dominique P Germain
    Division of Medical Genetics, hôpital Raymond Poincaré AP HP, University of Versailles St Quentin en Yvelines UVSQ, Garches, 92380, France
    Orphanet J Rare Dis 7:91. 2012
  5. pmc Severe infusion reactions to fabry enzyme replacement therapy: rechallenge after tracheostomy
    K Nicholls
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Vic, 3050, Australia
    JIMD Rep 5:109-12. 2012
  6. doi request reprint Increased arterial stiffness is associated with high cardiovascular mortality in male Fabry patients
    Kathleen Nicholls
    Department of Nephrology, Royal Melbourne Hospital, Grattan St, Parkville 3050, Vic, Australia
    J Inherit Metab Dis 35:885-9. 2012
  7. ncbi request reprint Prevention of progression of kidney disease: diabetic nephropathy - CARI guidelines
    Kathy Nicholls
    Royal Melbourne Hospital, Parkville, Victoria, Australia
    Aust Fam Physician 36:137-8. 2007
  8. ncbi request reprint Cardiac involvement in Fabry's disease
    Kathy Nicholls
    Department of Nephrology, The Royal Melbourne Hospital, Royal Parade, Parkville, Melbourne, VIC 3050, Australia
    Heart Lung Circ 14:S18-20. 2005
  9. ncbi request reprint The CARI guidelines. Prevention of progression of kidney disease
    David Harris
    Department of Renal Medicine, University of Sydney, Westmead Hospital, NSW
    Nephrology (Carlton) 11:S2-197. 2006
  10. ncbi request reprint Renal dialysis abatement: lessons from a social study
    Michael Ashby
    Palliative Care Unit, Southern Health, Monash Medical Centre
    Palliat Med 19:389-96. 2005

Collaborators

  • David Wayne Johnson
  • Merlin Thomas
  • Michael A Ashby
  • David I Harris
  • P G Kerr
  • Dominique P Germain
  • Mathu Selvarajah
  • Thanh T Nguyen
  • Jeff Castelli
  • Laura Barisoni
  • Charles J Jennette
  • Sheela Sitaraman
  • Roberto Giugliani
  • David J Lockhart
  • Atul Mehta
  • Pol F Boudes
  • Derralynn A Hughes
  • Alexander Bragat
  • Gavin J Becker
  • Tim D Hewitson
  • Andrew Crawford
  • Trevor Gin
  • Jason Galanos
  • Michael Low

Detail Information

Publications10

  1. ncbi request reprint Diabetic nephropathy--how might we prevent, retard, or cope with it?
    Kathy Nicholls
    Royal Melbourne Hospital, Parkville, Victoria
    Aust Fam Physician 34:933-6. 2005
    ..What can we do at the coal-face of medical practice to prevent nephropathy occurring at all, to identify it early if it develops, and to maximally limit its impact after its emergence?..
  2. ncbi request reprint Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre
    Thanh T Nguyen
    Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Clin Experiment Ophthalmol 33:164-8. 2005
    ..Fabry disease is a rare X-linked inborn error of glycosphingolipid metabolism. The aim of this study was to document the ophthalmological manifestations of patients attending the Royal Melbourne Hospital Fabry disease treatment centre...
  3. doi request reprint Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique
    Mathu Selvarajah
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Melbourne, Australia
    Nephrol Dial Transplant 26:3195-202. 2011
    ..The diagnosis is often missed or delayed, and specific diagnostic tests (serum α-Gal A activity, genotyping or biopsy) are expensive and not widely available. We evaluated the diagnostic potential of urine microscopy in AFD...
  4. pmc Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
    Dominique P Germain
    Division of Medical Genetics, hôpital Raymond Poincaré AP HP, University of Versailles St Quentin en Yvelines UVSQ, Garches, 92380, France
    Orphanet J Rare Dis 7:91. 2012
    ..We report on the safety and pharmacodynamics of migalastat hydrochloride, an investigational pharmacological chaperone given orally at 150 mg every-other-day...
  5. pmc Severe infusion reactions to fabry enzyme replacement therapy: rechallenge after tracheostomy
    K Nicholls
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Vic, 3050, Australia
    JIMD Rep 5:109-12. 2012
    ..Two years later, he has clinically improved on regular attenuated dose Agalsidase-beta, administered by slow infusion in a local hospital setting...
  6. doi request reprint Increased arterial stiffness is associated with high cardiovascular mortality in male Fabry patients
    Kathleen Nicholls
    Department of Nephrology, Royal Melbourne Hospital, Grattan St, Parkville 3050, Vic, Australia
    J Inherit Metab Dis 35:885-9. 2012
    ..The significant effect of elevated arterial stiffness, especially in a small cohort, argues for its clinical utility in individual patient risk assessment and for further intervention studies focusing on therapeutic reduction...
  7. ncbi request reprint Prevention of progression of kidney disease: diabetic nephropathy - CARI guidelines
    Kathy Nicholls
    Royal Melbourne Hospital, Parkville, Victoria, Australia
    Aust Fam Physician 36:137-8. 2007
    ..This article summarises CARI guidelines on the Prevention of progression of kidney disease: diabetic nephropathy...
  8. ncbi request reprint Cardiac involvement in Fabry's disease
    Kathy Nicholls
    Department of Nephrology, The Royal Melbourne Hospital, Royal Parade, Parkville, Melbourne, VIC 3050, Australia
    Heart Lung Circ 14:S18-20. 2005
    ..Disease frequency has probably been over-estimated at 1/40,000; so few centres have developed clinical experience of the disease, though the disease has been identified in all major racial groups...
  9. ncbi request reprint The CARI guidelines. Prevention of progression of kidney disease
    David Harris
    Department of Renal Medicine, University of Sydney, Westmead Hospital, NSW
    Nephrology (Carlton) 11:S2-197. 2006
  10. ncbi request reprint Renal dialysis abatement: lessons from a social study
    Michael Ashby
    Palliative Care Unit, Southern Health, Monash Medical Centre
    Palliat Med 19:389-96. 2005
    ..This study aimed to examine the reasons why some people chose to abate (i.e., stop or not start) renal dialysis, together with the personal and social impact of this decision on the person concerned, and/or their families...